Newsfile Corp
04 Nov 2026, 00:44 UTC · 27m ago
ROSEN, LEADING INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
Impact · against what's priced in
Tenax Therapeutics faces potential financial headwinds due to a securities class action lawsuit covering purchases between November 2023 and August 2026. This introduces new legal liability risks and potential settlement costs that could impact the company's balance sheet.
- TENX−0.30
No priced-in read yet





